Embecta Corp (EMBC) USD0.01

Sell:$15.00Buy:$15.02$0.30 (1.96%)

NASDAQ:0.45%
Market closed |
Prices delayed by at least 15 minutes
Sell:$15.00
Buy:$15.02
Change:$0.30 (1.96%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$15.00
Buy:$15.02
Change:$0.30 (1.96%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It has clearance from the FDA for its proprietary disposable insulin delivery system, which is indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D).

Key people

Devdatt Kurdikar
President, Chief Executive Officer, Director
Jacob Elguicze
Chief Financial Officer, Senior Vice President
Jean Casner
Chief Human Resource Officer, Senior Vice President
Colleen Riley
Senior Vice President, Chief Technology Officer
Jeffrey Z. Mann
Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
Ginny Blocki
Senior Vice President - Product Management and Global Marketing
Tom Blount
Senior Vice President and President, North America
Shaun Curtis
Senior Vice President - Global Manufacturing and Supply Chain
Anthony M. Roth
Vice President, Chief Accounting Officer, Corporate Controller
Slobodan Radumilo
Senior Vice President and President - International
David F. Melcher
Non-Executive Independent Chairman of the Board
Christopher R. Reidy
Director
David J. Albritton
Independent Director
Carrie L. Anderson
Independent Director
Robert J. Hombach
Independent Director
Click to see more

Key facts

  • EPIC
    EMBC
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US29082K1051
  • Market cap
    $875.52m
  • Employees
    2,100
  • Shares in issue
    58.49m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.